Invesco
TSHA icon

Invesco’s Taysha Gene Therapies TSHA Stock Holding History

Invesco’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
368,021
-964,759
-72% -$4.49M ﹤0.01% 2633
2025
Q4 		$7.33M Buy
1,332,780
+1,052,987
+376% +$5.11M ﹤0.01% 2043
2025
Q3 		$915K Buy
279,793
+76,122
+37% +$216K ﹤0.01% 2978
2025
Q2 		$470K Buy
203,671
+43,772
+27% +$95.1K ﹤0.01% 3182
2025
Q1 		$222K Buy
159,899
+72,544
+83% +$121K ﹤0.01% 3476
2024
Q4 		$151K Buy
87,355
+1,674
+2% +$3.47K ﹤0.01% 3564
2024
Q3 		$172K Sell
85,681
-312,069
-78% -$685K ﹤0.01% 3545
2024
Q2 		$891K Buy
+397,750
New +$1.16M ﹤0.01% 2991

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM